首页> 中文期刊> 《中国生化药物杂志》 >右美托咪定复合氯胺酮麻醉在先天性心脏病患儿心导管介入诊疗中的应用效果

右美托咪定复合氯胺酮麻醉在先天性心脏病患儿心导管介入诊疗中的应用效果

         

摘要

Objective To study the effect of dexmedetomidine combined with ketamine anesthesia on interventional therapy of children with congenital heart disease (CHD). Methods 40 cases of congenital heart disease were treated with catheter intervention from January 2013 to January 2017. The changes of pulmonary arterial pressure and the effect of anesthesia were compared before and after operation. Results 40 cases of children without surgical deaths, 36 cases of successful closure, the success rate of 90% of the operation, the patient after catheter intervention surgery after the results of the test were better than before and after treatment of children with pulmonary artery pressure (P<0.05), and the anesthesia effect was good in children. Conclusion The effect of dexmedetomidine combined with ketamine on the treatment of cardiac catheterization in children with congenital heart disease can achieve good results. The success rate of operation is high and safe, and it is highly reliable.%目的 研究右美托咪定复合氯胺酮麻醉在先天性心脏病患儿(CHD)心导管介入诊疗中的应用效果.方法 对自2013年1月~2017年1月在本院诊治的40例先天性心脏病患儿给予导管介入手术治疗,比较患儿手术治疗前后各项观察指标,肺动脉压改变情况以及分析麻醉效果.结果 40例患儿皆无手术死亡病例,成功封堵36例,手术成功率达到90%,患儿经导管介入手术治疗后各项检查指标结果均优于治疗前,术后患儿肺动脉压值基本达到平均值,差异有统计学意义(P<0.05),并且患儿麻醉效果良好.结论 右美托咪定复合氯胺酮麻醉在先天性心脏病患儿心导管介入诊疗中能够取得较好的效果,手术成功率高且安全,具有较高的可靠性.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号